Vertex Pharmaceuticals (VRTX) Net Income Growth (1y) (2010 - 2026)
Vertex Pharmaceuticals (VRTX) Net Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | 13.34% |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | -43.69% |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | -290.15% |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | -73.01% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.55 Bn | 54.80 Bn | 3.31 Bn | -10.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.59% |
| Dec 31, 2025 | 30.46% |
| Sep 30, 2025 | 3.59% |
| Jun 30, 2025 | 128.74% |
| Mar 31, 2025 | -41.22% |
| Dec 31, 2024 | -5.76% |
| Sep 30, 2024 | 0.98% |
| Jun 30, 2024 | -492.44% |
| Mar 31, 2024 | 57.13% |
| Dec 31, 2023 | 18.31% |
| Sep 30, 2023 | 11.26% |
| Jun 30, 2023 | 12.98% |
| Mar 31, 2023 | -8.17% |
| Dec 31, 2022 | 6.34% |
| Sep 30, 2022 | 9.23% |
| Jun 30, 2022 | 1,109.70% |
| Mar 31, 2022 | 16.69% |
| Dec 31, 2021 | 27.46% |
| Sep 30, 2021 | 27.64% |
| Jun 30, 2021 | -92.00% |